NCT06542432View on ClinicalTrials.gov

Utility and Effectiveness of Polygenic Risk Scoring (PRS) for Coronary Artery Disease (CAD)

NAEnrolling by invitationINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

July 1, 2029

Study Completion Date

July 1, 2029

Conditions
Coronary Artery DiseasePolygenic Risk ScoreHeart DiseasesCoronary DiseaseMyocardial InfarctionCardiovascular Diseases
Interventions
GENETIC

Disclosure of integrate risk score for coronary artery disease

Participants will receive their integrated risk score for coronary disease along with an optional genetic counseling visit to discuss the results.

Trial Locations (2)

19104

University of Pennsylvania, Philadelphia

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

MyOme

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

Mayo Clinic

OTHER

lead

MyOme

INDUSTRY